Back to Search
ANIL POTTI, MD
MD
Hematology & Oncology Physician
NPI: 1427122266IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
41326(MN)12312(ND)
Education
UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE
Class of 2000
Research & Publications (20)
Utilization of genomic signatures to direct use of primary chemotherapy.
PMID 18339540·Curr Opin Genet Dev·2008
6-review
Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future.
PMID 16805710·Expert Opin Biol Ther·2006
6-review
Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors.
PMID 15565811·Cancer Invest·2004
8-other
Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma.
PMID 14600832·J Cancer Res Clin Oncol·2004
8-other
An indolent B-cell lymphoma with t(2;8)(p12;q24) abnormality and absence of C-MYC amplification and TP53 deletion. A new variant?
PMID 12810261·Cancer Genet Cytogenet·2003
5-case
Prevalence of pesticide exposure in young males (</= 50 years) with adenocarcinoma of the prostate.
PMID 12890285·J Carcinog·2003
8-other
Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications.
PMID 14617373·J Carcinog·2003
8-other
CD117 (c-KIT) overexpression in patients with extensive-stage small-cell lung carcinoma.
PMID 12796027·Ann Oncol·2003
8-other
Immunoglobulin and T-cell receptor gene-gene rearrangement in pleural cavity-based T-cell rich B-cell lymphoma in an immunocompetent patient.
PMID 11908729·Leuk Lymphoma·2002
5-case
Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma.
PMID 12009234·Lung Cancer·2002
8-other
Identification of HER-2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia.
PMID 11679181·Lung Cancer·2001
8-other
Unusual presentations of thoracic tumors: Case 1. Acute adrenal insufficiency due to metastatic lung cancer.
PMID 11533102·J Clin Oncol·2001
5-case
Translating genomics into clinical practice: applications in lung cancer.
PMID 19508830·Curr Oncol Rep·2009
6-review
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
PMID 19383362·Mol Oncol·2009
8-other
Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
PMID 19636021·J Clin Oncol·2009
8-other
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.
PMID 19279207·Proc Natl Acad Sci U S A·2009
8-other
A genomic strategy to elucidate modules of oncogenic pathway signaling networks.
PMID 19362539·Mol Cell·2009
4-observational
An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
PMID 19638211·Breast Cancer Res·2009
4-observational
Genomic and molecular profiling predicts response to temozolomide in melanoma.
PMID 19147755·Clin Cancer Res·2009
8-other
Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma.
PMID 18922927·Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4101 N ROXBORO ST
DURHAM, NC 27704 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1427122266
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile